Scaling a bioprocess from R&D to manufacturing is challenging. Bioprocess modeling and simulation enables precise control over process conditions, improving efficiency and reducing variability. Our services offer a bioprocess digital twin approach to streamline development, leveraging advanced modeling to simulate and optimize conditions before running costly experiments.
Train bioprocess models using your experimental data to simulate and predict bioreactor outcomes. Bioprocess modeling and simulation enables rapid iteration and optimization, reducing costly trail-and-error experiments.
Use our custom bioreactors and expert team to conduct massive Design of Experiments (DOEs) for data-driven bioprocess optimization. Our approach supports multi-factor screening, robust testing, and other advanced experimental designs critical for scaling bioprocess digital twins.
Securely collaborate with our team to refine your bioprocess models and enhance predictive accuracy. We support data selection, model refinement, validation, and evaluation to ensure your bioprocess digital twin accurately represents real-world conditions for improved decision-making.
Combine your in-house data with experimental results generated by our team at Culture Biosciences to build robust bioprocess models. We support mechanistic modeling, hybrid approaches, predictive run-stopping models, and more, helping you confidently simulate and optimize processes.
Evaluate trade-offs between different Design of Experiments (DOE) strategies, including factor sensitivity and study fragility. Our modeling approach identifies optimal conditions for your experiments, reducing variability and improving process scale-up.
Use our high-performance bioprocess simulation tools to assess thousands of bioreactor conditions by integrating real experimental data with advanced computational models. Our bioprocess digital twin technology accelerates process development, enabling rapid, data-driven decision-making.
Our laboratories based in San Francisco are equipped with segregated modality suites, state-of-the-art bioreactors and analytical instrumentation, all operated by an experienced bioprocess development team.
